Genetic disease. Abnormal chromosomal and genetic finding on antenatal screening of mother
Conditions
Interventions
Intervention 1: Case groups : injection of enoxaparin 40 mg subcutaneously every 24 hours. Intervention 2: Case group : ASA( aspirin ) 80 mg orally every 24 hours. Intervention 3: Control group: non-u
Treatment - Drugs
Case groups : injection of enoxaparin 40 mg subcutaneously every 24 hours.
Case group : ASA( aspirin ) 80 mg orally every 24 hours
Control group: non-use of enoxaparin and aspirin
Sponsors
Vice chancellor for Research,Tabriz University Of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria :All women with homozygous mutations known thrombophilia and abortion or intrauterine death of two or three times or IUFD. Exclusion criteria :Anatomical abnormalities of the uterus and fallopian tubes; Diabetes; Hypothyroidism; PCOS; TORCH; Fetal anomalies; Cancel couples to cooperate with investigators and anything that causes a lack of access to the mother
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decolman. Timepoint: During pregnancy. Method of measurement: Ultrasound.;Premature birth. Timepoint: During pregnancy. Method of measurement: Physical examination.;Abortion. Timepoint: From start to 20 weeks. Method of measurement: Physical examination.;Full-term birth. Timepoint: During pregnancy. Method of measurement: Physical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Simin Taghavi
Tabriz University Of Medical Sciences
Outcome results
None listed